EGFR & ERBB2 Dimerization CHO
CBP74476
詢 價(jià)
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| N/A | |
| II. Description | |
| N/A | |
| II. Introduction | |
| Expressed gene: | EGFR & ERBB2 Dimerization |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+5μg/ml Puromycin+5 μg/ml Blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
 Figure 1. Recombinant EGFR & ERBB2 Dimerization CHO stably expressing EGFR & ERBB2.  Figure 2. Dose Response of Recombinant Human EGF in EGFR&ERBB2 Dimerization CHO (C18).
 Figure 3. Inhibition of Recombinant Human EGF induced EGFR&ERBB2 Dimerization by EGFR or ERBB2 Abs in EGFR&ERBB2 Dimerization CHO (C18). |
|
